These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 15376305)
1. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Kneteman NM; Oberholzer J; Al Saghier M; Meeberg GA; Blitz M; Ma MM; Wong WW; Gutfreund K; Mason AL; Jewell LD; Shapiro AM; Bain VG; Bigam DL Liver Transpl; 2004 Oct; 10(10):1301-11. PubMed ID: 15376305 [TBL] [Abstract][Full Text] [Related]
2. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Toso C; Meeberg GA; Bigam DL; Oberholzer J; Shapiro AM; Gutfreund K; Ma MM; Mason AL; Wong WW; Bain VG; Kneteman NM Transplantation; 2007 May; 83(9):1162-8. PubMed ID: 17496530 [TBL] [Abstract][Full Text] [Related]
3. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria. Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435 [TBL] [Abstract][Full Text] [Related]
4. Indications and management of everolimus after liver transplantation. Bilbao I; Sapisochin G; Dopazo C; Lazaro JL; Pou L; Castells L; Caralt M; Blanco L; Gantxegi A; Margarit C; Charco R Transplant Proc; 2009; 41(6):2172-6. PubMed ID: 19715864 [TBL] [Abstract][Full Text] [Related]
5. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001 [TBL] [Abstract][Full Text] [Related]
6. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Aishima S; Terashi T; Shimada M; Maehara Y Transplantation; 2007 Apr; 83(7):893-9. PubMed ID: 17460559 [TBL] [Abstract][Full Text] [Related]
7. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. Vivarelli M; Dazzi A; Zanello M; Cucchetti A; Cescon M; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD Transplantation; 2010 Jan; 89(2):227-31. PubMed ID: 20098287 [TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria. Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358 [TBL] [Abstract][Full Text] [Related]
9. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Vivarelli M; Cucchetti A; Piscaglia F; La Barba G; Bolondi L; Cavallari A; Pinna AD Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913 [TBL] [Abstract][Full Text] [Related]
10. Sirolimus therapy in liver transplant patients: an initial experience at a single center. Nocera A; Andorno E; Tagliamacco A; Morelli N; Bottino G; Ravazzoni F; Casaccia M; Barocci S; Alice S; Santori G; Ghirelli R; Valente U Transplant Proc; 2008; 40(6):1950-2. PubMed ID: 18675098 [TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria. Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412 [TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377 [TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284 [TBL] [Abstract][Full Text] [Related]
15. The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria. Ikegami T; Shimada M; Imura S; Yoshizumi T; Arakawa Y; Tokunaga T; Morine Y; Kanemura H Transplantation; 2008 Sep; 86(5):641-6. PubMed ID: 18791443 [TBL] [Abstract][Full Text] [Related]
16. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579 [TBL] [Abstract][Full Text] [Related]
17. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Herrero JI; Sangro B; Pardo F; Quiroga J; Iñarrairaegui M; Rotellar F; Montiel C; Alegre F; Prieto J Liver Transpl; 2008 Mar; 14(3):272-8. PubMed ID: 18306328 [TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma. Heimbach JK Cancer J; 2008; 14(2):95-9. PubMed ID: 18391614 [TBL] [Abstract][Full Text] [Related]
19. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma. Hu RH; Ho MC; Wu YM; Yu SC; Lee PH Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552 [TBL] [Abstract][Full Text] [Related]
20. [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria]. Fan J; Zhou J; Xu Y; Qiu SJ; Wu ZQ; Yu Y; Huang XW; Tang ZY; Wang YQ Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1227-31. PubMed ID: 16796876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]